Clinical trial • Phase I • Oncology

TERN-701 for Chronic Myeloid Leukemia

Phase I trial of TERN-701 for Chronic Myeloid Leukemia. 116 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Chronic Myeloid Leukemia
Trial Stage
Phase I

Key dates

Initial CTIS Submission Date
20-12-2023
First CTIS Authorization Date
22-04-2024

Trial design

Phase I trial across 25 sites in Germany, Spain, Italy and others.

Target Sample Size
116

Recruitment

Planned Sample Size
116
Recruitment Window Months
35

Geography

Total Number Of Sites
25
Total Number Of Participants
88

Germany

Earliest CTIS Part Ii Submission Date
02-04-2024
Latest Decision Or Authorization Date
08-09-2025
Processing Time Days
524
Number Of Sites
7
Number Of Participants
22

Sites

Site Name
Medizinische Hochschule Hannover
Department Name
Hematology, Hemostasis, Oncology and Stem Cell Transplantation
Principal Investigator Name
Florian Heidel
Principal Investigator Email
heidel.florian@mh-hannover.de
Contact Person Name
Florian Heidel
Contact Person Email
heidel.florian@mh-hannover.de
Site Name
Universitat Heidelberg
Department Name
III. Medizinische Klinik , Hämatologie und Internistische Onkologie
Principal Investigator Name
Susanne Saussele
Contact Person Name
Susanne Saussele
Site Name
Klinikum rechts der Isar der TU Muenchen AöR
Department Name
N/AKlinik und Poliklinik für Innere Medizin III
Principal Investigator Name
Peter Herhaus
Principal Investigator Email
peter.herhaus@mri.tum.de
Contact Person Name
Peter Herhaus
Contact Person Email
peter.herhaus@mri.tum.de
Site Name
Charite Universitaetsmedizin Berlin KöR
Department Name
Medizinische Klinik m. S. Hämatologie und Onkologie und Tumorimmunologie
Principal Investigator Name
Philipp Immanuel Le Coutre
Principal Investigator Email
philipp.lecoutre@charite.de
Contact Person Name
Philipp Immanuel Le Coutre
Contact Person Email
philipp.lecoutre@charite.de
Site Name
Universitaetsklinikum Aachen AöR
Department Name
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation
Principal Investigator Name
Martina Crysandt
Principal Investigator Email
mcrysandt@ukaachen.de
Contact Person Name
Martina Crysandt
Contact Person Email
mcrysandt@ukaachen.de
Site Name
Universitaetsklinikum Jena KöR
Department Name
Klinik für Innere Medizin II Abt. Hämatologie / Onkologie
Principal Investigator Name
Andreas Hochhaus
Principal Investigator Email
andreas.hochhaus@med.uni-jena.de
Contact Person Name
Andreas Hochhaus
Site Name
Goethe University Frankfurt
Department Name
Medizinische Klinik II Hämatologie/Onkologie Studienzentrale
Principal Investigator Name
Fabian Lang
Principal Investigator Email
studienservice@med.uni-frankfurt.de
Contact Person Name
Fabian Lang

Spain

Earliest CTIS Part Ii Submission Date
29-02-2024
Latest Decision Or Authorization Date
05-09-2025
Processing Time Days
554
Number Of Sites
9
Number Of Participants
35

Sites

Site Name
Hospital Universitario De Toledo
Department Name
Hematology
Principal Investigator Name
Luis Felipe Casado Montero
Principal Investigator Email
lfcasadom@gmail.com
Contact Person Name
Luis Felipe Casado Montero
Contact Person Email
lfcasadom@gmail.com
Site Name
Institut Catala D'oncologia
Department Name
Hematology
Principal Investigator Name
Blanca Xicoy Cirici
Principal Investigator Email
uicico_badalona@iconcologia.net
Contact Person Name
Blanca Xicoy Cirici
Site Name
Hospital Clinic De Barcelona
Department Name
Hematology
Principal Investigator Name
Ana Triguero Moreno
Principal Investigator Email
atriguero@clinic.cat
Contact Person Name
Ana Triguero Moreno
Contact Person Email
atriguero@clinic.cat
Site Name
Hospital Universitario Ramon Y Cajal
Department Name
Hematology
Principal Investigator Name
Valentín García-Gutiérrez
Principal Investigator Email
jvalentingg@gmail.com
Contact Person Name
Valentín García-Gutiérrez
Contact Person Email
jvalentingg@gmail.com
Site Name
Hospital Universitari Vall D Hebron
Department Name
Hematology
Principal Investigator Name
Sara Garrido Paniagua
Principal Investigator Email
saragarrido@vhio.net
Contact Person Name
Sara Garrido Paniagua
Contact Person Email
saragarrido@vhio.net
Site Name
Hospital Universitario 12 De Octubre
Department Name
Hematology
Principal Investigator Name
Gonzalo Carreño Gómez-Tarragona
Principal Investigator Email
gonzalo.carreno@salud.madrid.org
Contact Person Name
Gonzalo Carreño Gómez-Tarragona
Site Name
El Hospital Universitario De Gran Canaria Dr. Negrin
Department Name
Hematology
Principal Investigator Name
María Teresa Gómez Casares
Principal Investigator Email
mgomcasf@gobiernodecanarias.org
Contact Person Name
María Teresa Gómez Casares
Site Name
Hospital Quironsalud Zaragoza
Department Name
Hematology
Principal Investigator Name
Pilar Giraldo Castellano
Principal Investigator Email
giraldocastellano@gmail.com
Contact Person Name
Pilar Giraldo Castellano
Contact Person Email
giraldocastellano@gmail.com
Site Name
Hospital Universitario De La Princesa
Department Name
Hematology
Principal Investigator Name
María del Valle Gómez García de Soria
Principal Investigator Email
vallegomez@yahoo.com
Contact Person Name
María del Valle Gómez García de Soria
Contact Person Email
vallegomez@yahoo.com

Italy

Earliest CTIS Part Ii Submission Date
29-02-2024
Latest Decision Or Authorization Date
09-09-2025
Processing Time Days
558
Number Of Sites
3
Number Of Participants
12

Sites

Site Name
Fondazione IRCCS San Gerardo Dei Tintori
Department Name
SC Ematologia Adulti
Principal Investigator Name
Carlo Gambacorti Passerini
Principal Investigator Email
Carlo.gambacorti@unimib.it
Contact Person Name
Carlo Gambacorti Passerini
Contact Person Email
Carlo.gambacorti@unimib.it
Site Name
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Department Name
Dipartimento di Malattie Oncologiche edEmatologiche
Principal Investigator Name
Fausto Castagnetti
Principal Investigator Email
fausto.castagnetti@unibo.it
Contact Person Name
Fausto Castagnetti
Contact Person Email
fausto.castagnetti@unibo.it
Site Name
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Department Name
SC Ematologia
Principal Investigator Name
Alessandra Iurlo
Principal Investigator Email
alessandra.iurlo@policlinico.mi.it
Contact Person Name
Alessandra Iurlo

France

Earliest CTIS Part Ii Submission Date
26-03-2024
Latest Decision Or Authorization Date
05-09-2025
Processing Time Days
528
Number Of Sites
6
Number Of Participants
19

Sites

Site Name
Institut Paoli-Calmettes
Department Name
Hematology
Principal Investigator Name
Aude Charbonnier
Principal Investigator Email
charbonniera@ipc.unicancer.fr
Contact Person Name
Aude Charbonnier
Contact Person Email
charbonniera@ipc.unicancer.fr
Site Name
Hospital Hotel Dieu
Department Name
Clinical Hematology
Principal Investigator Name
Viviane Dubruille
Principal Investigator Email
viviane.dubruille@chu-nantes.fr
Contact Person Name
Viviane Dubruille
Site Name
Centre Hospitalier Lyon Sud
Department Name
Hematology
Principal Investigator Name
Marie Balsat
Principal Investigator Email
marie.balsat@chu-lyon.fr
Contact Person Name
Marie Balsat
Contact Person Email
marie.balsat@chu-lyon.fr
Site Name
Hopital Saint Louis
Department Name
Division of Hematology and Immunology Adult Hematology Department and Apheresis Unit
Principal Investigator Name
Delphine Rea
Principal Investigator Email
delphine.rea@aphp.fr
Contact Person Name
Delphine Rea
Contact Person Email
delphine.rea@aphp.fr
Site Name
Centre Leon Berard
Department Name
Medical Oncology
Principal Investigator Name
Franck-Emmanuel Nicolini
Principal Investigator Email
franck-emmanuel.nicolini@lyon.unicancer.fr
Contact Person Name
Franck-Emmanuel Nicolini
Site Name
Institut Bergonie
Department Name
Hematology Department
Principal Investigator Name
François-Xavier Mahon
Principal Investigator Email
f.mahon@bordeaux.unicancer.fr
Contact Person Name
François-Xavier Mahon
Contact Person Email
f.mahon@bordeaux.unicancer.fr

Sponsor

Primary sponsor

Full Name
Terns Inc.
Organisation Type
Pharmaceutical company
Country Of Registered Address
United States

Investigational products

Investigational Product Name
TERN-701

Related trials

Other published trials that may interest you.